Congratulations Drs. Rhodes and Levy; this is indeed an IMPRESSive undertaking
Thanks, Mary Ann Daly, RN BSN CCRN DC Regional Clinical Initiative Lead-Sepsis and ICU Liberation (ABCDE) Gordon and Betty Moore Foundation Grant Sutter Health Sacramento Sierra Region E-mail: [email protected]<mailto:[email protected]> Blackberry: 916.200.5604 Office: 916.614.6370 [cid:[email protected]] You never change things by fighting the existing reality. To change something, build a new model that makes the existing model obsolete. R. Buckminster Fuller From: [email protected] [mailto:[email protected]] On Behalf Of Lori Harmon Sent: Friday, August 30, 2013 1:10 PM To: [email protected] Subject: [Sepsis Groups] Important Announcement - IMPRESS study to be conducted Colleagues, The Surviving Sepsis Campaign will conduct a point prevalence study, the International Multicentre PREvalence Study on Sepsis <http://impress-ssc.com/> (IMPRESS), on November 7, 2013, to better understand the global burden of severe sepsis and septic shock in adult patients. Conducted by the Society of Critical Care Medicine and the European Society of Intensive Care Medicine, under the framework of the Surviving Sepsis Campaign, IMPRESS aims to help clinicians and researchers better understand the global burden of sepsis. De-identified patient-level data will be collected on patients presenting to a participating intensive care unit (ICU) or emergency department with severe sepsis or septic shock within a 24-hour period, midnight to midnight on November 7, 2013. Data collected as part of routine clinical care, including hospital and ICU characteristics, patient characteristics, severity of illness, adherence to Surviving Sepsis Campaign bundle elements, and mortality, will be used for this study. Led by investigators Andrew Rhodes, FRCP, FRCA, FFICM, and Mitchell M. Levy, MD, FCCM, the study will reveal important information that is currently lacking on the incidence of severe sepsis and septic shock throughout the world. These data will help inform the next steps toward improvement, as well as provide insights into the number of people who lose their lives to this illness. Interested hospitals from all countries are encouraged to visit www.impress-ssc.com/<http://www.impress-ssc.com/> for further details or to register for the study. Instructions and information on institutional review board approvals will be forthcoming. On behalf of the Surviving Sepsis Campaign, I extend an encouraging word to your team to mark this date and plan to participate in this very important groundbreaking event. Best, Lori A. Harmon, RRT, MBA Director, Program Development Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 O +1-847-493-6403 F +1-847-493-6428 [email protected]<mailto:[email protected]> http://www.sccm.org<http://www.sccm.org/>
<<inline: image001.png>>
_______________________________________________ Sepsisgroups mailing list [email protected] http://lists.sepsisgroups.org/listinfo.cgi/sepsisgroups-sepsisgroups.org
